Researchers developed a transgenic mouse model for prostate cancer using the prostate-specific rat probasin promoter to drive expression of the simian virus 40 large tumor antigen (Tag). Mice with high transgene expression developed progressive prostatic disease resembling human prostate cancer, ranging from mild intraepithelial hyperplasia to large multinodular malignant neoplasia. Prostate tumors were detected as early as 10 weeks of age, and immunohistochemical analysis showed that tumor cells expressed dorsolateral prostate-specific secretory proteins and had elevated nuclear p53 levels, similar to advanced human prostate cancer. The model also showed decreased androgen-receptor expression, a feature of advanced human prostate cancer. The transgenic mice provided a reproducible system to study the molecular basis of prostate cancer progression and metastasis. The model demonstrated that the rPB promoter is prostate-specific and that the transgenic strategy allows for the study of prostate cancer at various stages. The model also showed that prostate cancer can develop in male offspring of transgenic lines, and that the disease progresses with age. The study highlights the importance of developing animal models to understand the biology of prostate cancer and to evaluate new therapies. The model provides a valuable tool for studying the molecular mechanisms of prostate cancer and for developing strategies for its treatment and prevention.Researchers developed a transgenic mouse model for prostate cancer using the prostate-specific rat probasin promoter to drive expression of the simian virus 40 large tumor antigen (Tag). Mice with high transgene expression developed progressive prostatic disease resembling human prostate cancer, ranging from mild intraepithelial hyperplasia to large multinodular malignant neoplasia. Prostate tumors were detected as early as 10 weeks of age, and immunohistochemical analysis showed that tumor cells expressed dorsolateral prostate-specific secretory proteins and had elevated nuclear p53 levels, similar to advanced human prostate cancer. The model also showed decreased androgen-receptor expression, a feature of advanced human prostate cancer. The transgenic mice provided a reproducible system to study the molecular basis of prostate cancer progression and metastasis. The model demonstrated that the rPB promoter is prostate-specific and that the transgenic strategy allows for the study of prostate cancer at various stages. The model also showed that prostate cancer can develop in male offspring of transgenic lines, and that the disease progresses with age. The study highlights the importance of developing animal models to understand the biology of prostate cancer and to evaluate new therapies. The model provides a valuable tool for studying the molecular mechanisms of prostate cancer and for developing strategies for its treatment and prevention.